Template:Chromosomal abnormalities: Difference between revisions
From WikiMD's Wellness Encyclopedia
en>Buidhe reorganize, there are no articles on autosomal monosomies |
CSV import |
||
| Line 8: | Line 8: | ||
| list1 = {{Navbox|child | | list1 = {{Navbox|child | ||
|group1= | | group1 = [[Trisomy|Trisomies]]/Tetrasomies | ||
|list1= | | list1 = | ||
*[[ | * [[Down syndrome]] | ||
*[[ | ** [[Chromosome 21|21]] | ||
* [[ | * [[Edwards syndrome]] | ||
** [[Chromosome 18|18]] | |||
* [[Patau syndrome]] | |||
** [[Chromosome 13|13]] | |||
* [[Trisomy 9]] | * [[Trisomy 9]] | ||
* [[Tetrasomy 9p]] | * [[Tetrasomy 9p]] | ||
*[[ | * [[Trisomy 8|Warkany syndrome 2]] | ||
* [[ | ** [[Chromosome 8|8]] | ||
** [[Chromosome | * [[Cat eye syndrome]]/[[Trisomy 22]] | ||
** [[Chromosome 22|22]] | |||
* [[Trisomy 16]] | * [[Trisomy 16]] | ||
| group2 = [[Deletion (genetics)| | | group2 = [[Monosomy|Monosomies]]/[[Deletion (genetics)|deletions]] | ||
| list2 = | | list2 = | ||
* ( | * ([[1q21.1 deletion syndrome]]/[[1q21.1 duplication syndrome]]/[[TAR syndrome]]/[[1p36 deletion syndrome]]) | ||
** [[Chromosome 1|1]] | ** [[Chromosome 1|1]] | ||
* [[Wolf–Hirschhorn syndrome]] | * [[Wolf–Hirschhorn syndrome]] | ||
| Line 40: | Line 37: | ||
* [[Jacobsen syndrome]] | * [[Jacobsen syndrome]] | ||
** [[Chromosome 11|11]] | ** [[Chromosome 11|11]] | ||
* [[Miller–Dieker syndrome]]/[[Smith–Magenis | * [[Miller–Dieker syndrome]]/[[Smith–Magenis syndrome]] | ||
** [[Chromosome 17|17]] | ** [[Chromosome 17|17]] | ||
* [[DiGeorge syndrome]] | * [[DiGeorge syndrome]] | ||
| Line 59: | Line 56: | ||
| list2 = {{Navbox|child | | list2 = {{Navbox|child | ||
| group1 = [[Monosomy | | group1 = [[Monosomy]] | ||
| list1 = | | list1 = | ||
* [[Turner syndrome|Turner syndrome (45,X)]] | * [[Turner syndrome|Turner syndrome (45,X)]] | ||
| group2 = [[Trisomy | | group2 = [[Trisomy]]/[[tetrasomy]],<br />[[Aneuploidy|other karyotypes]]/[[Mosaic (genetics)|mosaics]] | ||
| list2 = | | list2 = | ||
* [[Klinefelter syndrome|Klinefelter syndrome (47,XXY)]] | * [[Klinefelter syndrome|Klinefelter syndrome (47,XXY)]] | ||
* [[XXYY syndrome|XXYY syndrome (48,XXYY)]] | * [[XXYY syndrome|XXYY syndrome (48,XXYY)]] | ||
* [[XXXY syndrome|XXXY syndrome (48,XXXY)]] | * [[XXXY syndrome|XXXY syndrome (48,XXXY)]] | ||
* [[XXXYY | * [[49,XXXYY|49,XXXYY]] | ||
* [[ | * [[49,XXXXY]] | ||
* [[ | * [[Triple X syndrome|Triple X syndrome (47,XXX)]] | ||
* [[Tetrasomy X|Tetrasomy X (48,XXXX)]] | * [[Tetrasomy X|Tetrasomy X (48,XXXX)]] | ||
* [[Pentasomy X| | * [[Pentasomy X|49,XXXXX]] | ||
* [[XYY syndrome| | * [[XYY syndrome|Jacobs syndrome (47,XYY)]] | ||
* [[XYYY | * [[48,XYYY|48,XYYY]] | ||
* [[XYYYY | * [[49,XYYYY|49,XYYYY]] | ||
* [[45,X/46,XY mosaicism|45,X/46,XY]] | * [[45,X/46,XY mosaicism|45,X/46,XY]] | ||
| Line 92: | Line 89: | ||
| group1 = Lymphoid | | group1 = Lymphoid | ||
| list1 = | | list1 = | ||
* [[Burkitt lymphoma]] t(8 [[Myc|MYC]];14 [[IGH@|IGH]]) | * [[Burkitt's lymphoma]] t(8 [[Myc|MYC]];14 [[IGH@|IGH]]) | ||
* [[Follicular lymphoma]] t(14 [[IGH@|IGH]];18 [[Bcl-2|BCL2]]) | * [[Follicular lymphoma]] t(14 [[IGH@|IGH]];18 [[Bcl-2|BCL2]]) | ||
* [[Mantle cell lymphoma]]/[[Multiple myeloma]] | * [[Mantle cell lymphoma]]/[[Multiple myeloma]] t(11 [[Cyclin D1|CCND1]]:14 [[IGH@|IGH]]) | ||
* [[Anaplastic large-cell lymphoma ]] t(2 [[Anaplastic lymphoma kinase|ALK]];5 [[NPM1]]) | * [[Anaplastic large-cell lymphoma ]] t(2 [[Anaplastic lymphoma kinase|ALK]];5 [[NPM1]]) | ||
* [[Acute lymphoblastic leukemia]] | * [[Acute lymphoblastic leukemia]] | ||
| Line 109: | Line 106: | ||
| group2 = Other | | group2 = Other | ||
| list2 = | | list2 = | ||
* [[Ewing sarcoma]] t(11 [[FLI1]]; 22 [[ | * [[Ewing's sarcoma]] t(11 [[FLI1]]; 22 [[Ewing sarcoma breakpoint region 1|EWS]]) | ||
* [[Synovial sarcoma]] t(x [[SYT1|SYT]];18 [[Synovial sarcoma, X breakpoint|SSX]]) | * [[Synovial sarcoma]] t(x [[SYT1|SYT]];18 [[Synovial sarcoma, X breakpoint|SSX]]) | ||
* [[Dermatofibrosarcoma protuberans]] t(17 [[Collagen, type I, alpha 1|COL1A1]];22 [[PDGFB]]) | * [[Dermatofibrosarcoma protuberans]] t(17 [[Collagen, type I, alpha 1|COL1A1]];22 [[PDGFB]]) | ||
* [[Myxoid liposarcoma]] t(12 [[DNA damage-inducible transcript 3|DDIT3]]; 16 [[ | * [[Myxoid liposarcoma]] t(12 [[DNA damage-inducible transcript 3|DDIT3]]; 16 [[FUS (gene)|FUS]]) | ||
* [[Desmoplastic small-round-cell tumor]] t(11 [[ | * [[Desmoplastic small-round-cell tumor]] t(11 [[WT1]]; 22 [[Ewing sarcoma breakpoint region 1|EWS]]) | ||
* [[Alveolar rhabdomyosarcoma]] t(2 [[PAX3]]; 13 [[ | * [[Alveolar rhabdomyosarcoma]] t(2 [[PAX3]]; 13 [[FOXO1]]) t (1 [[PAX7]]; 13 [[FOXO1]]) | ||
}} | }} | ||
| Line 122: | Line 119: | ||
* [[Fragile X syndrome]] | * [[Fragile X syndrome]] | ||
* [[Uniparental disomy]] | * [[Uniparental disomy]] | ||
* [[XX male syndrome]]/[[ | * [[XX male syndrome]]/[[46,XX testicular disorders of sex development]] | ||
* [[Marker chromosome]] | * [[Marker chromosome]] | ||
* [[Ring chromosome]] | * [[Ring chromosome]] | ||
** [[Ring chromosome 6|6]]; [[Ring chromosome 9|9]]; [[Ring chromosome 14 syndrome|14]]; [[Ring chromosome 15|15]]; [[Ring | ** [[Ring chromosome 6|6]]; [[Ring chromosome 9|9]]; [[Ring chromosome 14 syndrome|14]]; [[Ring chromosome 15|15]]; [[Ring 18|18]]; [[Ring chromosome 20 syndrome|20]]; [[Ring chromosome 21|21]], [[Ring chromosome 22|22]] | ||
}}<noinclude> | }}<noinclude> | ||
{{collapsible option}} | {{collapsible option}} | ||
[[Category:Genetic disease and disorder templates by mechanism]] | [[Category:Genetic disease and disorder templates by mechanism]] | ||
</noinclude> | |||
{{no-index-template}} | |||
Revision as of 05:34, 30 April 2024
| Chromosome abnormalities | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|